23/07/2026
Vitamin D really did slow telomere loss, and it did so in the kind of trial that should make you take the finding seriously.
In the VITAL Telomere study, 2,000 IU of vitamin D3 a day reduced the shortening of leukocyte telomeres over four years. The number the study actually produced was 140 base pairs. The number the internet produced was "3.5 to 4.7 years younger," and the distance between those two figures is the whole story.
VITAL was a large, double-blind, placebo-controlled trial in 25,871 US adults, built as a two-by-two factorial testing 2,000 IU of vitamin D3 and 1 gram of marine omega-3s against placebo over five years. The telomere arm followed 1,054 of those participants, measuring leukocyte telomere length at baseline, year 2, and year 4 across more than 2,500 samples. This matters because the telomere outcome was pre-specified, the primary endpoint the analysis was designed around, not a measure fished out after the fact. That alone puts it a tier above the post hoc aging-clock analyses that generate most "supplement reverses aging" headlines. Vitamin D moved the needle. Omega-3 did nothing to telomere length at either timepoint.
The size of the effect is worth noting. Vitamin D preserved about 140 base pairs of telomere over four years, and against a typical telomere of roughly 7,000 base pairs, that is on the order of 2 percent. The trend held in the same direction year over year, and the result cleared statistical significance, though the margin was thin enough that it should be read as a real but modest signal rather than a robust one. This is a genuine finding. It is also a small one.
Take the 140 base pairs vitamin D preserved, divide by an assumed rate of telomere loss somewhere around 30 to 40 base pairs per year, and you arrive at three to five years. The arithmetic is defensible, but it launders a narrow molecular measurement into a sweeping claim about lifespan. The authors themselves were restrained, concluding only that vitamin D "might have a role in counteracting telomere erosion or cell senescence."
Telomere length is a noisy stand-in for aging, and the strongest evidence of that is what happens when you check it against a different biomarker. In the DO-HEALTH trial, the same 2,000 IU of vitamin D did nothing to four DNA-methylation aging clocks. So the two most cited molecular yardsticks for biological age disagree about the same supplement at the same dose: telomeres say vitamin D helped, the methylation clocks say it did not. When your proxies contradict each other, the honest conclusion is that the proxies are imperfect, not that one of them has measured your remaining years.
A daily 2,000 IU of vitamin D produced a small, real reduction in telomere shortening in a rigorous trial, omega-3 did not, and telomere length is a marker of cellular aging whose link to how long or how well a person actually lives remains unsettled. That is a reason to keep vitamin D in the "plausibly worth it" column, especially at a dose this ordinary. It is not evidence that a supplement bought you four years.
What the study never did is follow anyone forward to see whether preserving those 140 base pairs changed a single hard outcome, which is the only test that would turn "younger telomeres" into "a longer life."
Zhu H, Manson JE, Lee IM, et al. Vitamin D3 and marine omega-3 fatty acids supplementation and leukocyte telomere length: 4-year findings from the VITAL randomized controlled trial. DOI 10.1016/j.ajcnut.2025.05.003. PMID 40409468.
